Previous 10 | Next 10 |
Full Year 2022 guidance of $46-48M, an increase of 46% - 52% over 2021 unaudited revenue of approximately $31.5M. Q1 2022 guidance of $11.5M, a 111% Increase over Q1 2021 revenue. Q4 2021 booking meets expectations. LOS ANGELES, Jan. 10, 2022 (GLOBE NEWSWIRE) -- via Invest...
Zacks Investment Research recently raised its forecast for SRAX’s 4Q21 revenues to $10.05mn, representing +122.3% YoY growth Zacks have also upped their fiscal year 2022 revenue forecast to $42.52 million, implying +35% YoY growth SRAX’s implied results look even more im...
SRAX (NASDAQ: SRAX) , a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, has scheduled several industry-specific events for 2022. The company has announced its initial schedule for 2022 confe...
LOS ANGELES, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has announced their preliminary list of industry specific conferences...
SRAX (NASDAQ: SRAX) , a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has recently announced that it will no longer have to consolidate the financials of its former subsid...
SRAX’s Sequire SaaS platform, and popular investors and industry conferences, provide unique opportunities for investors and public companies to connect and communicate The 2021 Sequire Clean Tech & Electric Vehicles Conference was held on December 6th, featuring panels, keyn...
SRAX (NASDAQ: SRAX) is a diversified financial technology, digital marketing and consumer data management company that provides an array of consumer data to its clients, valuable to marketing and communications. Its flagship offering is a premier investor intelligence and communications pl...
Lexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global innovator in drug delivery platforms, has announced its entry into an advertising and media agreement for media buys and digital marketing with SRAX (NASDAQ: SRAX) . Under the agreement, SRAX will act as the agent for Lexaria and will eng...
SRAX (NASDAQ: SRAX) , a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, recently published its third-quarter 2021 results. “SRAX reported third-quarter revenues of $8...
SRAX’s BIGtoken platform announced their merger with BritePool Inc on September 27th, with both entities officially completing their merger on December 2, 2021 SRAX have simultaneously revealed that they will no longer consolidate BIGtoken’s financials within their financi...
News, Short Squeeze, Breakout and More Instantly...
Westlake Village, CA, May 08, 2024 (GLOBE NEWSWIRE) -- SRAX Inc. (OTC: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its SaaS platform Sequire, announced today it has entered into a definitive merger agreement with DNA Holdings Venture ...
BioHarvest Sciences Inc (CNVCF) is expected to report for quarter end 2023-12-31 QS Energy Inc (QSEP) is expected to report for Q4 2023 NKGen Biotech Inc. (NKGN) is expected to report for Q4 2023 Cal-Maine Foods Inc. (CALM) is expected to report for Q3 2024 Davide Campari (DVDCF) ...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...